Bexsero is a vaccine used to protect against meningococcal group B (MenB), one of the most common causes of meningitis and blood poisoning, particularly in infants, children, adolescents, and young adults.
Meningococcal disease can develop rapidly and may be life-threatening. Vaccination helps reduce the risk of infection and serious complications.
Vaccination course
Infants
-
Given as a multi-dose course, starting from early infancy
-
Schedule depends on age at first dose
Children, adolescents & adults
-
Usually given as a 2-dose course
-
Doses are spaced at least 1 month apart
Your healthcare professional will advise the exact schedule based on age and risk.
